Super Religare Laboratories Ltd (SRL), a subsidiary of Fortis Healthcare Ltd, is looking to file its draft red herring prospectus (DRHP) with the securities market regulator SEBI to float a public issue in the next six months, a... Register ... VC Circle, 4 days ago
Piramal Enterprises is exiting its early discovery research and focusing more on late stage clinical development, Swati Piramal, Vice-Chairperson, Piramal Enterprises, confirmed. Discovery research has a long gestation period and the company's ...Hindu Business Line, 1 month ago
Data for 800 companies from Bombay Stock Exchange. Values are: days closing price, previous closing price in brackets, 52-week low and high in bold, and volume traded (in 000) in brackets. GROUP A A A B B 1044.35(1038.4) 1200-448 (17) A C C 1409.6(1400.0) ...Deccan Herald, 2 months ago Stock Prices as on Jul 22, 2014 Deccan Herald, 2 months ago
Private equity firm CX Partners is likely to reap a return of 3X (three times) over its four-year-old investment in diagnostics major Thyrocare Technologies. According to people in the know, the $500-million fund will dilute 25 per cent of its 27 ...Business Standard India, 2 months ago
on your WebpageAdd Widget >Get your members hooked!